INDIANAPOLIS, Sept. 10, 2024. Eli Lilly and Company today announced detailed results from the QWINT-2 phase 3 trial evaluating once-weekly insulin...

INDIANAPOLIS, Sept. 10, 2024. Eli Lilly and Company today announced detailed results from the QWINT-2 phase 3 trial evaluating once-weekly insulin...

Diabetes affects over 37 million people in the U.S., with many of them living with type 2 diabetes. This form of diabetes used to be most common among...

Diabetes affects over 37 million people in the U.S., with many of them living with type 2 diabetes. This form of diabetes used to be most common among...

In the near future, the insulin delivery devices industry is poised for remarkable advancements that promise to revolutionize diabetes management....

The chemotherapy drug cisplatin is a lifesaver for many adults and children diagnosed with cancer, but it often causes hearing loss, a side effect...

The chemotherapy drug cisplatin is a lifesaver for many adults and children diagnosed with cancer, but it often causes hearing loss, a side effect...

MONDAY, Sept. 9, 2024 -- Diabetics who fly with an insulin pump could find themselves with lower-than-normal blood sugar levels, a new study...